Omid Mirmosayyeb

3.4k total citations
180 papers, 1.4k citations indexed

About

Omid Mirmosayyeb is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Omid Mirmosayyeb has authored 180 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Pathology and Forensic Medicine, 60 papers in Neurology and 25 papers in Rheumatology. Recurrent topics in Omid Mirmosayyeb's work include Multiple Sclerosis Research Studies (114 papers), Peripheral Neuropathies and Disorders (24 papers) and Long-Term Effects of COVID-19 (23 papers). Omid Mirmosayyeb is often cited by papers focused on Multiple Sclerosis Research Studies (114 papers), Peripheral Neuropathies and Disorders (24 papers) and Long-Term Effects of COVID-19 (23 papers). Omid Mirmosayyeb collaborates with scholars based in Iran, United States and Nepal. Omid Mirmosayyeb's co-authors include Mahdi Barzegar, Vahid Shaygannejad, Nasim Nehzat, Vahid Shaygannejad, Mahsa Ghajarzadeh, Alireza Afshari-Safavi, Saeed Vaheb, Sara Bagherieh, Dena Sadeghi Bahmani and Shervin Badihian and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Omid Mirmosayyeb

159 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omid Mirmosayyeb Iran 18 825 541 249 190 153 180 1.4k
Vahid Shaygannejad Iran 21 1.1k 1.3× 528 1.0× 129 0.5× 183 1.0× 203 1.3× 202 1.9k
Bardia Nourbakhsh United States 18 877 1.1× 357 0.7× 108 0.4× 268 1.4× 138 0.9× 58 1.5k
Shay Menascu Israel 20 772 0.9× 361 0.7× 465 1.9× 198 1.0× 60 0.4× 77 1.6k
Benjamin M. Jacobs United Kingdom 17 395 0.5× 377 0.7× 107 0.4× 252 1.3× 106 0.7× 50 1.3k
Kyla A. McKay Sweden 21 1.2k 1.4× 287 0.5× 60 0.2× 119 0.6× 192 1.3× 54 1.5k
Tessel F. Runia Netherlands 14 603 0.7× 213 0.4× 166 0.7× 748 3.9× 98 0.6× 20 1.5k
Lahar Mehta United States 17 586 0.7× 278 0.5× 68 0.3× 180 0.9× 109 0.7× 36 1.1k
M. Mateo Paz Soldán United States 16 484 0.6× 305 0.6× 160 0.6× 705 3.7× 115 0.8× 37 1.5k
Marianna Cortese United States 18 948 1.1× 378 0.7× 168 0.7× 368 1.9× 222 1.5× 44 2.1k
Giuseppe Fenu Italy 23 1.0k 1.2× 341 0.6× 48 0.2× 213 1.1× 218 1.4× 92 1.5k

Countries citing papers authored by Omid Mirmosayyeb

Since Specialization
Citations

This map shows the geographic impact of Omid Mirmosayyeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omid Mirmosayyeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omid Mirmosayyeb more than expected).

Fields of papers citing papers by Omid Mirmosayyeb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omid Mirmosayyeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omid Mirmosayyeb. The network helps show where Omid Mirmosayyeb may publish in the future.

Co-authorship network of co-authors of Omid Mirmosayyeb

This figure shows the co-authorship network connecting the top 25 collaborators of Omid Mirmosayyeb. A scholar is included among the top collaborators of Omid Mirmosayyeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omid Mirmosayyeb. Omid Mirmosayyeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mirmosayyeb, Omid, Niels Bergsland, Robert Zivadinov, et al.. (2025). Personality traits and disease worsening in multiple sclerosis: Associations with neuroticism and conscientiousness. Multiple Sclerosis and Related Disorders. 100. 106559–106559.
2.
Mirmosayyeb, Omid, Bianca Weinstock‐Guttman, Robert Zivadinov, & Dejan Jakimovski. (2025). Anatomy-driven segmentation of parafoveal optical coherence tomography (OCT) measures may improve associations with clinical outcomes in multiple sclerosis. Journal of Neurology. 272(2). 141–141. 1 indexed citations
3.
Mirmosayyeb, Omid, et al.. (2025). Suicide Ideation, Attempts, and Mortality in Multiple Sclerosis: A Systematic Review and Meta‐Analysis. Brain and Behavior. 15(9). e70839–e70839. 1 indexed citations
4.
Vaheb, Saeed, et al.. (2024). Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): An updated systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. 87. 105681–105681. 8 indexed citations
5.
Shaygannejad, Vahid, et al.. (2024). Abnormal body mass index is associated with risk of multiple sclerosis: A systematic review and meta-analysis. Obesity Research & Clinical Practice. 18(5). 311–321. 3 indexed citations
6.
7.
Jakimovski, Dejan, Katelyn Kavak, Kara Patrick, et al.. (2024). Post-Partum Clinical and Patient-Reported Outcome Changes in Mothers with Multiple Sclerosis: Findings from the NAPPREMS Study. Medicina. 60(7). 1159–1159.
8.
Vaheb, Saeed, et al.. (2024). The role of parental consanguinity and familial aggregation in development of multiple sclerosis: a case–control study. European journal of medical research. 29(1). 503–503.
9.
Mirmosayyeb, Omid, et al.. (2024). Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer. Cancers. 16(3). 619–619. 17 indexed citations
10.
Shah, Sangam, et al.. (2024). Risk of dementia following herpes zoster infection among patients undertreatment versus those not: A systematic review and meta‐analysis. Health Science Reports. 7(3). e1941–e1941. 3 indexed citations
11.
Morrow, Sarah A., Omid Mirmosayyeb, Devon Conway, et al.. (2023). Detecting isolated cognitive relapses in persons with MS. Multiple Sclerosis Journal. 29(14). 1786–1794. 7 indexed citations
12.
Shaygannejad, Vahid, et al.. (2022). The Role of Cobalamin on Interleukin 10, Osteopontin, and Related MicroRNAs in Multiple Sclerosis. Iranian Journal of Allergy Asthma and Immunology. 21(3). 332–343. 1 indexed citations
13.
Barzegar, Mahdi, Erfan Sadeghi, Sara Bagherieh, et al.. (2022). Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis. SHILAP Revista de lepidopterología. 2022. 1–13. 10 indexed citations
14.
Barzegar, Mahdi, Saeed Vaheb, Omid Mirmosayyeb, et al.. (2021). Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study. Multiple Sclerosis and Related Disorders. 52. 102947–102947. 46 indexed citations
15.
Khoshnood, Reza Jalili, Alireza Zali, Mahsa Ghajarzadeh, et al.. (2021). Parkinson’s disease and COVID-19: a systematic review and meta-analysis. Neurological Sciences. 43(2). 775–783. 19 indexed citations
16.
Mirmosayyeb, Omid, Marjan Mansourian, Mahdi Barzegar, et al.. (2020). Omega 3 Supplementation Can Regulate Inflammatory States in Gas Station Workers: A Double-Blind Placebo-Controlled Clinical Trial. Journal of Interferon & Cytokine Research. 40(5). 262–267. 1 indexed citations
17.
18.
Eskandari, Nahid, et al.. (2018). Expression of OX40 Gene and its Serum Levels in Neuromyelitis Optica Patients. BioMolecular Concepts. 10(1). 62–67. 2 indexed citations
19.
Mousavi, Seyed Ali, et al.. (2017). Effect of cerebrolysin in patients with ischemic stroke: A double-blind randomized control study. SHILAP Revista de lepidopterología. 4(4). 247–249. 1 indexed citations
20.
Eskandari, Nahid, et al.. (2015). A short review on structure and role of cyclic-3',5'-adenosine monophosphate-specific phosphodiesterase 4 as a treatment tool. Journal of Research in Pharmacy Practice. 4(4). 175–175. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vahid Shaygannejad Breakdown of academic impact, for papers by Bardia Nourbakhsh Breakdown of academic impact, for papers by Shay Menascu Breakdown of academic impact, for papers by Benjamin M. Jacobs Breakdown of academic impact, for papers by Kyla A. McKay Breakdown of academic impact, for papers by Tessel F. Runia Breakdown of academic impact, for papers by Lahar Mehta Breakdown of academic impact, for papers by M. Mateo Paz Soldán Breakdown of academic impact, for papers by Marianna Cortese Breakdown of academic impact, for papers by Giuseppe Fenu
Rankless by CCL
2026